Copyright
Avalado por
Antibodies
Bacterial pneumonia
Influenza-like illness
Ipd
Neutrophils
Older adults
Pars
Pneumococcal bacteremia
Pneumococcal conjugate vaccine
Pneumococcus
Proteases
Pspk
S. Pneumoniae
Serotypes pcv13 and ppv23
Streptococcus pneumonia
Streptococcus pneumoniae
Surveillance
Vaccines
13 valent pneumococcal conjugate vaccine
Acute otitis media
Antibiotic susceptibility
Bacteremia
Child
Children
Conjugate vaccines
Emerging serotypes
Immunization
Indirect protection
Invasive disease potential
Invasive pneumococcal disease
Israel epidemiology
Outcome
Pcv13
Pediatric
Penicillin
Pneumococcal conjugate vaccine
Pneumococci
Sepsis
Serotype 3
Serotype replacement
Streptococcus pneumoniae
Vaccination
13-valent pneumococcal
Acute cardiac events
Chronic disease
Clinical features
Coinfection
Community-acquired pneumonia
Drug resistance
Genotype
Herd immunity
Influenza virus
Invasive pneumococcal disease
Microbial
Mortality
Nasal washing
Outcome
Pneumococcal conjugate vaccine
Pneumococcal pneumonia
Prognostic factors
Serotype
Streptococcus pneumoniae
Surveillance
Vaccine
Para cualquier consulta o incidencia contacte con faqs@cmep-infectious.com
Curso acreditado con 5,9 créditos de formación continuada para la profesión de medicina.
